The cortisol response to psychosocial stress may become dysregulated in stress-related disorders. It is potentiated by pituitary secretion of adrenocorticotropic hormone (ACTH), which is, in part, regulated by arginine vasopressin receptor-1B (AVPR1B). AVPR1B variants were previously reported to associate with mood and anxiety disorders. This study aims, for the first time, to investigate association of AVPR1B genetic variants with mood and anxiety outcomes in suicidal behavior.Using a family-based study design of 660 complete nuclear family trios with offspring who have made a suicide attempt (SA), we tested the direct association and linkage of AVPR1B single nucleotide polymorphisms (SNPs) with SA, as well as with depression and anxiety in SA. Main findings were the association and linkage of AVPR1B exon 1 SNP rs33990840 and a major 6-SNP haplotype representative of all common AVPR1B-SNPs, on the outcome of high Beck Depression Inventory scores in SA. By contrast, genetic associations with lifetime diagnoses of depression and anxiety in SA or gene-environment interactions between AVPR1B variants and stressful life events (SLEs) were not significant. An exploratory screen of interactions between AVPR1B and CRHR1 (corticotropin-releasing hormone receptor-1), the principal pituitary regulator of ACTH secretion, showed no support for gene-gene interactions on the studied outcomes. The results suggest that AVPR1B genetic variation, eg, non-synonymous SNP rs33990840 mediating putative consequences on ligand binding, has a role in SA etiology characterized by elevated depression symptoms, without involving AVPR1B-moderation of SLEs.
INTRODUCTION
A dysregulated cortisol response to psychosocial stress is often observed in suicidal behavior, mood, and anxiety disorders and may be assessed by dexamethasone (DEX) non-suppression, one of the best known biological predictors of completed suicide in depression (Mann et al, 2006) . Although corticotropin-releasing hormone (CRH) signaling via CRH receptor-1 (CRHR1) is the principal activation pathway of the stress-reactive hypothalamicpituitary-adrenal (HPA) axis, arginine vasopressin (AVP) signaling via AVP receptor-1B (AVPR1B) may act synergistically in response to certain stressors (Scott and Dinan 1998) . Furthermore, CRH challenge combined with DEX (CRH/DEX), which is putatively more sensitive in detecting hypothalamic AVP dysregulation than DEX, has also been used in assessing stress-related disorders, eg, depression (Bardeleben and Holsboer 1989; Purba et al, 1996) . Increased AVP signaling in HPA axis stress reactivity has additionally been shown to occur following exposure to chronic psychosocial stressors, which are commonly thought to underlie chronic stress-related disorders, eg, depression (Scott and Dinan 1998; Bao and Swaab 2010) .
Single nucleotide polymorphisms (SNPs) and haplotypes in AVPR1B were previously observed to associate with stressrelated mood and anxiety disorders (van West et al, 2004; Dempster et al, 2007; Keck et al, 2008; van West et al, 2009; Leszczynska-Rodziewicz et al, 2012) . AVPR1B knockout in animal models suggest that the gene is involved in response to multiple stressors, in addition to chronic stressors (Roper et al, 2011) . This genetic evidence is supported by a reduction in stress-related outcomes in response to AVPR1B pharmacological blockade in animal models, and antagonists are currently in development for stress-related disorders (Griebel et al, 2005; Roper et al, 2011) .
However, the precise role of AVPR1B genetic variation in stress reactivity and treatment outcomes in stress-related disorders is still unclear. In two recent studies, AVPR1B SNPs did not moderate a reduction in depressive symptoms in response to citalopram or cortisol response to a socio-evaluative stressor . Evidence for variation in other HPA axis candidate genes,eg, CRHR1, has been more consistent across studies of cortisol response, suicidality, mood, and anxiety disorders (Binder and Nemeroff 2010) . To date, there has been no study on gene-environment interaction (G Â E) between AVPR1B variants and stressful life events (SLEs) on any outcome.
In line with previous evidence of AVP/AVPR1B stressrelated signaling in animals and humans (Scott and Dinan 1998; Bao and Swaab 2010) , G Â Es may be hypothesized between AVPR1B variants and SLEs represented by chronic/ repeated and interpersonal, network-related psychosocial stressors, on the outcome of suicide attempt (SA), as well as depression and anxiety in SA. Although AVPR1B and CRHR1 are not expressed exclusively in HPA axis, a potential role for AVPR1B variation in HPA axis activation might also be observed by interaction with CRHR1 variants that associated with cortisol response. Variants of AVPR1B and CRHR1 were previously shown to have combined genetic effects in association with panic disorder, suggesting the potential for observing gene-gene interaction effects (G Â Gs) in adequately powered studies (Keck et al, 2008) . Moreover, AVPR1B and CRHR1 are capable of physically interacting (Young et al, 2007) , and heterodimerization affects their pharmacological properties in vitro (Murat et al, 2012) . However, heterodimerization in vivo or G Â Gs on stress-related outcomes have not been shown.
To complement and extend previously published AVPR1B associations on mood and anxiety disorders, we tested here two succeeding hypotheses in a family-based association study. The primary hypothesis of our study was that (i) AVPR1B is a candidate gene of interest in overall SA etiology, or in the etiology of a subset of SA outcomes characterized by depression, anxiety, and/or sex, whereby SNPs were expected to directly associate with those outcomes. We then continued with testing the second hypothesis of (ii) interactions between AVPR1B genetic variants and SLEs on those SA outcomes, by using G Â E analyses. Finally, we also wished to characterize the influence of other non-hypothesized factors on any associations identified, as well as to conduct an exploratory screen for putative G Â Gs between AVPR1B and CRHR1 SNPs on the studied SA outcomes.
SUBJECTS AND METHODS

Research Subjects
Research subjects were collected in Ukraine in [2001] [2002] [2003] [2004] [2005] [2006] , numbering 660 complete and extensively quality-controlled nuclear family trios with SA offspring and 519 healthy volunteers (HVs), as described previously (Wasserman et al, 2005; Ben-Efraim et al, 2011) . Of the 267 trios previously analyzed in our initial publication (Wasserman et al, 2005) , 199 trios were also used in the present analysis of 660 trios (68 trios omitted due to DNA-concentration incompatibilities with the currently used genotyping platform). The collection of research subjects followed the code of ethics of the World Medical Association (Declaration of Helsinki), and a written consent was obtained. The study was approved by the Research Ethics Committee at the Karolinska Institute and by the Ministry of Health in Ukraine. Selection criteria, sample demographics, International Classification of Diseases 10th edition (ICD-10) psychiatric diagnoses, and DNA preparation and genotyping have been described previously for trios (Wasserman et al, 2008) and HVs (Ben-Efraim et al, 2011) . Briefly, SA offspring were Ukrainian citizens with 94.1% having X3 grandparents of Ukrainian/ Russian ethnicity, 51.1% were male and 48.9% were female, with mean ages of 24.6 (SD ± 7.3) and 23.8 (SD ± 7.1) years, respectively. HVs were unrelated to trios with 93.8% having X3 grandparents of Ukrainian/Russian ethnicity, 45.9% were male and 54.1% were female, with mean ages of 35.7 (SD ± 16.1) and 34.6 (SD ± 14.8) years, respectively. Anxiety, depression, and depressive symptoms are frequently observed to associate with a dysregulated HPA axis as well as suicidal behavior and may be intermediate outcomes linking other diagnoses, eg, alcohol use disorders and psychoses, respectively, with suicidal behavior (Lönnqvist 2009 ). Therefore, we did not exclude subjects with any specific psychiatric diagnosis before analysis.A more comprehensive description is also provided (Supplement).
Polymorphisms
We selected 13 AVPR1B SNPs for genotyping (SNP&SEQ Technology Platform, Uppsala, Sweden), according to SNPs previously identified in association studies on panic disorder and recurrent major depression (van West et al, 2004; Keck et al, 2008) or in dbSNP (http://www.ncbi. nlm.nih.gov/snp) in putatively functional positions such as promoter, untranslated regions, or exons ( Figure 1a ). One genotyped SNP was monomorphic (rs35775245, all CC homozygotes) and therefore removed from further analysis. The remaining 12 genotyped SNPs (Table 1) were in Hardy-Weinberg Equilibrium (P40.05), had high call rates (X 99.8%), absence of mendelian inheritance errors, and 100% intra-assay reproducibility.We then proceeded to cover as much of the coding and flanking regions as possible by imputation of untyped 'common' SNPs (MAF X0.05) with a European ancestry reference (EUR) panel (The 1000 Genomes Project Consortium 2010) using software BEAGLE v3.3 (Browning and Browning 2009) , as described previously and modified here for the novel reference panel (Supplement). After postimputation processing and linkage disequilibrium (LD)-pruning as previously described , four common genotyped (non-imputed) SNPs and one common imputed SNP remained for analysis ( Figure 1 and Table 1 ). The four genotyped (non-imputed) SNPs and one imputed SNP (BEAGLE allelic r 2 ¼ 1) tagged by high LD (r 2 threshold ¼ 0.80) all the 38 other (either genotyped or imputable) common SNPs (with MAF X0.05) present in the AVPR1B coding region, flanking 5 kb upstream and 0 kb downstream of the untranslated regions (Table 1) . Any associations to be discovered with these five selected SNPs could thus be confirmed retrospectively to exist also for the other corresponding SNPs being tagged (Table 1 ). In addition, one genotyped SNP with low-frequency (MAF ¼ 0.019) was included in analysis (rs36046834; Figure 1 ).For G Â G investigation of AVPR1B Â CRHR1, five CRHR1variants were selected out of a larger genotyped panel according to previous associations with cortisol level changes, depression, anxiety, or suicidality (Supplement).
SLEs
Environmental exposures were assessed as described previously (Ben-Efraim et al, 2011). SLE types were either studied alone or aggregated according to exploratory assessment of exposure to chronic/repeated and interpersonal, network-related psychosocial stressors (Supplement). Overall, SLEs analyzed as dichotomous variables were: (1) childhood/adolescence physical assault, (2) childhood/ adolescence sexual assault, (3) lifetime SLEs checklist (median-split), (4) lifetime SLEs checklist network subscale (median-split), (5) repeated assault (physical or sexual assault in both childhood/adolescence and adulthood), and (6) childhood/adolescence assault and median-or-greater ('high') lifetime SLEs.
Outcome Measures
Trio subjects were interviewed in their home environment within 4 weeks (median 11 days) after the ascertained index SA. All index SA had a score of X2 on the Medical Damage Rating Scale (Beck et al, 1975) , the main outcome measure of the study. SA offspring were also assessed for depression and anxiety disorders and depressive symptoms. Lifetime diagnoses of depression and anxiety disorders were assessed with the Composite International Diagnostic Interview v2.1(World Health Organization 1997), according to ICD-10 codes F32-F33, F34.1 (depression or dysthymia, n ¼ 142 SA offsprings) or F40-45 (neurotic, stress-related and somatoform disorders, n ¼ 176 SA offsprings). Self-report of current depressive symptoms with the Beck Depression Inventory (BDI; Beck et al, 1961 ) was completed at their homes by the subjects with the trained interviewer present in the same room, while taking precautions not to influence the subject replies, occurring after the diagnostic assessment and before the blood sampling. A BDI score X17 was used to analyze subjects with 'high' current depressive symptoms ('high-BDI'; n ¼ 298 SA offsprings, n ¼ 39 HVs).Subjects were not under influence of alcohol or drugs during interview, and past year alcohol-drug use disorders were equally prevalent among low-and high-BDI subjects (B20%). Last month (ie, predating the SA, 'pre-SA') use of (any) psychotropic medication was more prevalent in high-(34%) vs low-BDI subjects (17%; P ¼ 0.001). Furthermore, last month pre-SA use of selective serotonin re-uptake inhibitors (SSRIs) was more prevalent in high-(13%) vs low-BDI subjects (4%; Po0.001). The same interview procedure was used for the HVs, ascertained for not having any history of lifetime SA or psychiatric diagnosis, after recruitment from workplaces in Odessa in 2003 and 2005 . Secondary outcome measures used to characterize any Notes: Additionally, one genotyped and rare (MAF ¼ 0.017) SNP rs36046834 was analyzed in the study (major and minor alleles G/C, base pair position 206224830), as well as haplotypes of all six SNPs together (ie, rs35630000-rs33911258-rs36046834-rs33990840-rs28529127-rs33933482, with major haplotype CTGGGG, f ¼ 0.82). The SNPs selected for analysis tagged all the other known, common SNP variation in the AVPR1B genes with r 2 X0.80 as follows: -rs35630000 tagged rs34786964, rs28535253, rs35076969. -rs33911258 tagged rs33985287, rs28750713, rs28517619, rs28733981, rs35394684, rs28870717, rs28878533, rs28520962, rs61434100, rs28373064, rs33940624, rs28607590, rs35997092. -rs33990840 tagged rs28536160, rs33932943, rs35608965. -rs28529127 tagged rs28632197, rs34327164, rs33971119, rs35369693, rs33935503, rs28588803, rs28766023, rs35810727, rs34792278. -rs33933482 tagged rs28499431, rs28425623, rs28380027, rs3883899, rs28483632, rs28477649, rs28676508, rs28452187, rs28575468, rs63611260. a On chromosome 1, genome build 37.3/assembly GRCh37.
Family-based study of AVPR1B in suicide attempts YJ Ben-Efraim et al findings are also described (Supplement). Complete BDI score questionnaires were available for 98.6% (n ¼ 651) of SA subjects.
Statistical Analyses
Analyses of Hardy-Weinberg equilibrium, genetic association, G Â E, effect size estimation, covariation with secondary outcomes, and power analysis has been described previously (Ben-Efraim et al, 2011; Sokolowski et al, 2012) (Asimit and Zeggini 2010) . Tests of additive Â additive G Â G were performed using 15 pseudosibs per case (Cordell et al, 2004) , as implemented in software trio (Schwender et al, 2011) . P-values (two-tailed) not corrected for multiple comparisons (nominal) are shown. The multiple tests performed in the analysis of the first hypothesis (i) (n ¼ 54 SNPs and n ¼ 45 haplotype tests) were corrected for by determining the number of independent variables by spectral decomposition (http://gump.qimr.edu.au/general/daleN/) (Nyholt 2004) , revealing that 4.023 genetic variables had been investigated in three sample strata, yielding a corrected significance threshold of P ¼ 0.00414. After testing the second hypothesis (ii) of G Â Es (n ¼ 129 tests), all P-values (n ¼ 228) generated in the study (Supplementary Figure S1) for hypothesis (i) þ (ii) were included in false discovery rate (FDR) analysis (Strimmer 2008) . Results that passed the first correction and that according to the false discovery rate did not contain any false positives, are herein referred to as significant main results. Odds ratios (ORs) with 80% power (using a ¼ 0.01, log-additive model, n ¼ 660 trios, population risk ¼ 0.01) for the common SNPs analyzed here (Table 1) were in the range between 1.4-1.6 for the total sample and in the range between 1.6-1.9 for the sexstratified analyses (0.184MAF40.07). Further, power calculations also are shown in Supplementary Table S1 .
RESULTS
AVPR1B Genetic Variants show Direct association and Linkage on SAwith High Depressive Symptoms and with No role for G Â Es
To test the first hypothesis, we analyzed the family-based association and linkage of six selected SNPs, as well as 6-SNP haplotypes thereof (Figure 1 and Table 1), on the outcomes of SA, SA with high current depressive symptoms (high-BDI), or SA with depression and anxiety disorders, among male and female separately or combined (n ¼ 99 tests). Table 2 shows the top associations observed after this analysis (at nominal Po0.01), wherein the top two P-values withstood correction for multiple testing by the number of statistically independent variables analyzed (n ¼ 12.07). All findings with high-BDI described in Table 2 were also nominally significant (Po0.05) in the total SA sample (n ¼ 660 trios; data not shown).To test the second hypothesis, we used the same genetic markers and SA outcomes as in the first hypothesis but instead analyzed the G Â Es using six different environmental exposures; high lifetime SLEs, high network-related SLEs, childhood/adolescence physical assault, childhood/adolescence sexual assault, combined childhood/adolescence assaults and high lifetime SLEs, as well as repeated childhood/adolescence or adulthood assaults, respectively (n ¼ 129 tests). None of the G Â E analyses revealed Po0.01, despite the reasonable power to observe such effects for many of the analyses performed (see Supplementary Methods and Supplementary  Table S1 ).Finally, false discovery rate analysis of all P-values generated in the two hypotheses tested (n ¼ 228, Supplementary Figure S2) , showed that the top four associations in Table 2 had Qo0.25 (ie, o1 false positive among them). The results together suggested AVPR1B to be a candidate gene of interest in SA etiology characterized by high-BDI, with main results driven by direct associations of SNP rs33990840 and the 6-SNP haplotype, and with no significant role for G Â Es.
Follow-Up Characterization of the Main Results
We then conducted several follow-up analyses, investigating various other factors that might be relevant in relation to the main results reported, by eg., re-analyzing subgroups in relation to those factors or re-analysis in the presence of interaction-terms. Table 2 shows the results of analysis in low-BDI subjects, with results being non-significant, in contrast to the main results for high-BDI. This relative difference was the greatest for the main result with SNP rs33900840 (Table 2 ; P LRT o0.05).We further observed that the main results with high-BDI were driven by the borderline-to-moderate ranges of clinically interpreted depressive symptoms (Figure 2) .
The main results were best fit by the additive model (data not shown), as was used in the hypothesis testing stage. The allelic direction and additive effect of SNP rs33990840 was also confirmed in a less-powered case-control re-analysis for high-BDI SA outcome (OR ¼ 1.74). More detailed sliding window haplotype analysis showed multiple 2-SNP haplotypes with similar frequency, allelic direction, and significance, being representative of the main results with SNP rs33990840 (data not shown). Two 2-SNP haplotypes of SNPs rs33990840-rs33911258, showed particularly parsimonious minor vs major allele and under-vs overtransmissions, respectively, comparable to those observed with the SNPs (Tables 2 vs 3) .
Sex effects did not significantly contribute to the main results (data not shown). Although, eg, results for SNPs rs33900840 and rs33911258 were nominally significant in males for high-BDI in SA, they were observed with significance in the males and females combined ( Table 2) . The minor result for low-frequency SNP rs36046834 was observed only in male high-BDI offspring (Table 2 ) but on the background that SNPs rs36046834 and rs33990840 were equivalent in 29 out of 30 individuals (data not shown). For the last month pre-SA use of any kind of psychotropic medications or SSRIs, past year alcohol-drug use disorders, or the presence of 12.9% psychotic subjects in the sample, the main results were retained in absence of those factors (Po0.05) and with no covariate interaction observed (P LRT 40.05). Nevertheless, the ORs for SNPs rs33990840 and rs33911258 on high-BDI were elevated (compared with Table 2 ) among subjects with last month pre-SA use of any psychotropic medications (ORs 2.6 and 2.1, respectively) or SSRIs (ORs 3.3 and 2.5, respectively). Concerning further SA-related secondary outcome measures (Supplement), the SA subjects driving the main result of SNP rs33990840 (Table 2 ) could also be characterized as having used a nonviolent SA method (P LRT ¼ 0.0047) and by scoring below the sample median on the Trait Anger Scale (P LRT ¼ 0.03).
Exploratory G Â G Analyses Between AVPR1B and CRHR1
Screening through G Â Gs on all SA outcomes investigated herein failed to indicate any putative interaction effects between AVPR1B and CRHR1 SNPs (all P40.05; data not shown), despite the reasonable power to observe such effects for many of the analyses conducted (see Supplementary  Methods and Supplementary Table S1 )
DISCUSSION
This study showed for the first time thatAVPR1B variants were linked and associated with SA characterized by high-BDI, mainly driven by association of the previously unreported exon 1 SNP rs33990840 and a 6-SNP haplotype representing all known common SNP variation in AVPR1B. The haplotypes over-and under-transmitted reflected the transmission distortion observed with the all single-SNP analyses (Tables 2 and 3 and text), whereby major alleles could be interpreted as 'risk' and minor alleles as 'protective' alleles, respectively. According to LD analysis and haplotype mapping, those risk vs protective allelic effects on high-BDI SA were captured most parsimoniously by using corresponding 2-SNP haplotypes of SNPs rs33911258 and rs33990840 (Table 3) .
Other potentially interesting SNPs were tagged by our associated SNPs (Table 1) , according to a novel EUR reference panel for AVPR1B(The 1000 Genomes Project The main genetic associations identified were in the range between borderline clinical and moderate depressive symptoms in suicide attempt (SA). Follow-up characterization of the 6-SNP haplotype is shown along more detailed, clinically interpreted cutoffs on the Beck Depression Inventory (BDI) score scale, with results being representative also for single nucleotide polymorphisms (SNPs) rs33990840 and rs33911258 (not shown here). The family-based association analysis was conducted using trios, with bars showing the allelic transmission odds ratios ( ± SE) for SA offspring in either the normal (BDI score 0-10; n ¼ 248), mild (BDI score 11-16; n ¼ 109), borderline clinical (BDI score 17-20; n ¼ 71), moderate (BDI score 21-30; n ¼ 128), or severe-extreme (BDI score 21-30; n ¼ 95) range of current depressive symptoms. *Po0.05.
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). Minor alleles of rs33985287 and rs28536160 were protective in females in a previous association and linkage study on childhood-onset mood disorders (Dempster et al, 2007) and rs28536160 minor allele was protective on bipolar disorder with psychotic features (Leszczynska-Rodziewicz et al, 2012) . These results were in the same allelic direction as we observed with SNPs rs33911258 and rs33990840, which tag rs33985287 and rs28536160, respectively (Table 1) . SNP rs28536160 was also genotyped herein (Table 1 ) and a transmission distortion in the same allelic direction was confirmed (data not shown).
A risk effect of the major allele haplotype in trios was also congruent with Dempster et al (2007) . In contrast to Dempster et al (2007) , however, the associations were observed here without sex specificity. The results herein were not congruent with other previously observed SNP associations on recurrent major depression (van West et al, 2004) , panic disorder (Keck et al, 2008) , and attentiondeficit hyperactivity disorder (van West et al, 2009) , and a protective effect of a major allele haplotype in two of these studies (van West et al, 2004; van West et al, 2009) . Our results most closely match those of Dempster et al (2007) . Perhaps this may be explained by similar methods and outcomes: both Dempster et al (2007) and this study used family-based designs and therefore the associations were robust to population stratification, and childhoodonset major depression is an established endophenotype of suicidal behavior (Mann et al, 2009) . Ethnic differences between studies may also be important in the absence of population stratification. Differential ethnicity-dependent selection signatures on AVPR1B were reported, suggesting that AVPR1B was subjected to natural selection during human evolutionary history and balancing selection in Europeans (Cagliani et al, 2009) . A study in an ethnically diverse sample did not observe an association with antidepressant treatment outcome . Major allele risk effects congruent to our results were observed across psychiatric outcomes in Hungarians (Dempster et al, 2007) , Poles (Leszczynska-Rodziewicz et al, 2012) , and Ukrainians (here) vs major allele protective effects in Belgians (van West et al, 2004; van West et al, 2009) and Swedes (van West et al, 2004) and a recessive risk effect in Germans (Keck et al, 2008) . This may be supported by intra-European patrilineal haplogroup clines that are separated by central European geographic boundaries (Rosser et al, 2000) . Notably, genetic boundaries were determined to a greater extent by geographic rather than linguistic boundaries, ie, genetic boundaries between Hungary and its neighbors were not significant relative to continental geographic boundaries (Rosser et al, 2000) . In separate studies, Poles and Ukrainians were found to share a common patrilineal heritage together with southwestern Russians (Balanovsky et al, 2008) while Poles and Germans were genetically separated according to the present political boundary (Kayser et al, 2005) . Nevertheless, intraEuropean selection signatures on AVPR1B have not been studied and thus any correlation with patrilineal boundaries is speculative. Also, not all results here were congruent with Dempster et al (2007) , ie, we did not observe significance in the total sampleof non-synonymous exon 2 SNP rs35369693 (tagged by rs28529127 and NS for an allelic test in the total sample and by sex in this study). However, rs35369693 was imputed here with relatively lower accuracy (Figure 1 ) while sex-specific genotypic effects were not tested due to insufficient transmissions.
Potential Causal Roles of Associated SNPs in Pathogenesis of Depressive Symptoms in SA
This study showed novel direct association of rs33990840 on SA and high current depressive symptoms in SA. Although the study design did not permit us to exclude other unknown environmental influences during the interviews that might have influenced the BDI score assessments, we found no reasons as to why such influences would occur non-randomly (causing bias) and the dichotomization of BDI scores should insulate against such influences on particular BDI items. However, the last month pre-SA use of SSRIs may have lowered the range of BDI scores we observed among the SA subjects who were driving the association in high-BDI (Figure 2 and text) . Rs33990840 translates to 191Gly4Arg, which was previously predicted to affect receptor activation according to its position in the second extracellular loop (Supplementary Figure S1 ) and proximity to two putative AVP-binding residues (Cagliani et al, 2009) . This study supports the functional prediction by showing rs33990840 transmission distortion and altered risk for having depressive symptoms in SA.
The associated SNPs may instead be in high LD with functional variants. Both rs33990840 and rs33911258 are in extensive LD with SNPs in the 5 0 flanking region (Figure 1  and Table 1 ), which contains several sequence motifs that are highly conserved between human, rat, and mouse, suggesting a role in AVPR1B expression (Rene and de Keyzer 2002) . Specifically in humans, the 5 0 region contains an open reading frame, putative transcription factor binding sites for sex and stress hormones, and sequence for a spliced antisense transcript that is expressed in pituitary and which may affect AVPR1B transcription and/ or translation (Sugimoto et al, 1994; Rene et al, 2000) .
AVPR1B G Â E vs Genetic Associations
A previous study found no association of AVPR1B SNPs on DEX suppression in response to an acute psychosocial stressor . Putative AVPR1B Â SLEs or AVPR1B Â CRHR1 were not observed here, despite several of these tests achieving sufficient power (Supplementary  Table S3 ), as shown also by our previous investigations, eg, of CRHR1 with multiple significant G Â Es observed (BenEfraim et al, 2011) .Taken together, this suggests that AVPR1B common SNPs did not moderate the effect of SLEs either directly or indirectly via SLE-moderating CRHR1 variants and that the genetics of AVPR1B vs CRHR1 on SA in our sample may be distinct. As inferred by having observed no SLE-moderating effects, a role for AVPR1B common SNPs in stress reactivity was not supported here. However, we did observe direct genetic associations with SA. Accumulated observations in our sample and others shows that HPA axis regulatory genes, as well as other genes, are directly associated with suicidal behavior (Wasserman et al, 2007; Brezo et al, 2008) , in line with a diversified genetic etiology. It is noteworthy that we have previously observed genetic associations (in the currently used trio data set) of common SNPs in neural conduction and neurotransmitter release (Wasserman et al, 2005) , monoaminergic signaling (Wasserman et al, 2007; BenEfraim et al, 2012) , and glutamatergic signaling genes . Interestingly, potential functional roles that are not directly related to mediating stress reactivity in depression and suicidal behavior have been shown for dysregulation of AVP (Merali et al, 2006; Mlynarik et al, 2007; Bao and Swaab 2010) , but the role of AVPR1B genetics is still poorly understood.
CONCLUSION
AVPR1B variants were associated with SA for the first time, predominantly concurrent with high depressive symptoms. The observed associations are congruent with a previous family-based study on childhood-onset mood disorders (Dempster et al, 2007) , although sex specificity was not observed here. No role for common AVPR1B SNPs, as effect-modifiers of certain SLEs or CRHR1 variants in SA, or depression and anxiety in SA was observed. Future studies of AVPR1B genetic variation and stress-related outcomes would benefit from studies in other ethnic populations and testing sex-specificity. Equally interesting are the polymorphisms with regard to the HPA axis function and potentially AVPR1B-CRHR1 heterodimerization. Finally, it would be interesting to know whether 191Gly4Arg (rs 33990840) changes the pharmacological (antidepressant) response to AVPR1B antagonists.
